Novo Nordisk India has announced a partnership with Healthify to create an AI-enabled patient support program specifically for individuals living with obesity. This program aims to enhance patient experience and treatment results by offering structured, AI-assisted lifestyle guidance. The AI assistant will help users monitor their nutrition during various stages of their treatment journey. Healthify's co-founder, Tushar Vashisht, emphasized the importance of structured lifestyle support alongside GLP-1 therapy for effective obesity care. The initiative seeks to provide patients with the necessary tools and coaching to foster healthier long-term habits. Vikrant Shrotriya, Managing Director of Novo Nordisk India, highlighted that combining medication with comprehensive patient guidance is crucial for sustained obesity care, marking this program as a significant step toward improving patient outcomes.